Alto Neuroscience ANRO

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
-$0.25 (-6.33%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

Business overview of Alto Neuroscience (ANRO)
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.

Key Insights

Critical company metrics and information

  • Latest Closing Price

    $3.55

  • Market Cap

    $95.74 Million

  • Total Outstanding Shares

    26.97 Million Shares

  • Total Employees

    88

  • Dividend

    No dividend

  • IPO Date

    February 2, 2024

  • SIC Description

    Pharmaceutical Preparations

  • Primary Exchange

    New York Stock Exchange

  • Type

    Common Stock

  • Headquarters

    650 castro street, suite 450, Mountain view, CA, 94041

  • Homepage

    https://www.altoneuroscience.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Other Current Assets$182.67 Million
Fixed Assets$2.35 Million
Accounts Payable$2.25 Million
Temporary Equity Attributable To Parent$0
Wages$3.88 Million
Assets$191.61 Million

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Recent Headlines From The Web

Latest news, press releases, and media coverage about ANRO from trusted financial sources
    All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

    ⓒ 2025 Financhle. All Rights Reserved.